Capital International Ltd. CA Buys 43,479 Shares of The Cooper Companies, Inc. $COO

Capital International Ltd. CA boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 61.5% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 114,124 shares of the medical device company’s stock after purchasing an additional 43,479 shares during the quarter. Capital International Ltd. CA’s holdings in Cooper Companies were worth $7,824,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares during the last quarter. Assetmark Inc. lifted its position in Cooper Companies by 357.8% during the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after purchasing an additional 483 shares during the period. Resona Asset Management Co. Ltd. boosted its stake in shares of Cooper Companies by 7.9% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 67,988 shares of the medical device company’s stock valued at $4,838,000 after purchasing an additional 4,976 shares during the last quarter. Wedbush Securities Inc. grew its position in shares of Cooper Companies by 13.5% during the 2nd quarter. Wedbush Securities Inc. now owns 13,860 shares of the medical device company’s stock worth $986,000 after buying an additional 1,648 shares during the period. Finally, Fox Run Management L.L.C. bought a new stake in shares of Cooper Companies during the second quarter worth approximately $514,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of COO opened at $75.82 on Tuesday. The stock has a 50 day simple moving average of $81.98 and a 200 day simple moving average of $76.02. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The firm has a market capitalization of $14.79 billion, a PE ratio of 37.53, a P/E/G ratio of 2.13 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm posted $0.92 earnings per share. The business’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Key Stories Impacting Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Insiders (CEO, directors and other executives) purchased shares in recent months, reinforcing management confidence in the business and complementing continuing share repurchases — a constructive signal for investors. CooperCompanies Insiders Buy as Rebound Setup Forms
• Positive Sentiment: An unnamed report raised Cooper’s price target to $103, reflecting upside from current levels and highlighting bullish analyst conviction after the quarter and buyback activity. Cooper Companies (NASDAQ:COO) Price Target Raised to $103.00
• Neutral Sentiment: Analyst/education pieces (Zacks) reiterate Cooper as a longer-term value/quality healthcare name but flag the importance of monitoring international revenue trends — useful for longer-horizon investors but not immediate catalysts. Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term
• Neutral Sentiment: Another Zacks piece recommends watching geographic/international revenue trends for their impact on estimates — informative but not an immediate driver. Investing in The Cooper Companies (COO)? Don’t Miss Assessing Its International Revenue Trends
• Negative Sentiment: Citigroup reduced its price target to $87, signaling caution from some institutional analysts despite the recent earnings beat; conflicting analyst views are likely contributing to short-term selling pressure. Citigroup Cuts Cooper Companies (NASDAQ:COO) Price Target to $87.00

Wall Street Analysts Forecast Growth

A number of analysts have commented on COO shares. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a report on Friday, January 9th. Barclays upped their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday. Mizuho set a $100.00 target price on Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $90.79.

Insider Buying and Selling

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the stock in a transaction dated Wednesday, December 17th. The shares were bought at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the acquisition, the director directly owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction that occurred on Tuesday, December 16th. The shares were acquired at an average price of $80.80 per share, with a total value of $808,000.00. Following the acquisition, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at $19,081,000.80. The trade was a 4.42% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders purchased 16,014 shares of company stock valued at $1,304,416. Corporate insiders own 2.08% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.